STRYKER CORP (SYK) FY2025 Q1 P&L / Income Statement

STRYKER CORP (SYK) FY2025 Q1 P&L / Income Statement

Income statement for 2025-01-01 through 2025-03-31. View: Segments by Product and Service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Net sales

5,866,000,000 US dollars

Cost of sales

2,122,000,000 US dollars

Gross profit

3,744,000,000 US dollars

Total operating expenses

2,907,000,000 US dollars

Operating income

837,000,000 US dollars

Other income (expense), net

negative 73,000,000 US dollars

Earnings before income taxes

764,000,000 US dollars

Income taxes

110,000,000 US dollars

Net earnings

654,000,000 US dollars

MedSurg and Neurotechnology - Endoscopy

867,000,000 US dollars

MedSurg and Neurotechnology - Instruments

730,000,000 US dollars

MedSurg and Neurotechnology - Medical

945,000,000 US dollars

MedSurg and Neurotechnology - Neuro Cranial

563,000,000 US dollars

MedSurg and Neurotechnology - Vascular

406,000,000 US dollars

Orthopaedics - Hips

443,000,000 US dollars

Orthopaedics - Knees

639,000,000 US dollars

Orthopaedics - Other

162,000,000 US dollars

Orthopaedics - Spinal Implants

166,000,000 US dollars

Orthopaedics - Trauma and Extremities

945,000,000 US dollars

Research, development and engineering expenses

405,000,000 US dollars

Selling, general and administrative expenses

2,300,000,000 US dollars

Amortization of intangible assets

167,000,000 US dollars

Asset impairments

35,000,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.